Stock listing
NASDAQ:RNAM Avidity Biosciences, Inc Stock
Follow Avidity Biosciences, Inc into a list and get an email when it puts out news.
Last close · NASDAQ:RNAM
$71.34 USD
Close on Feb 26, 2026 · No longer trades
- Lowest – highest close
- $4.87 – $72.93 USDSince Jun 12, 2020 · lowest Oct 27, 2023 · highest Feb 3, 2026
Delisted NASDAQ:RNAM no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:RNAM
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Avidity Biosciences, Inc on 6ix
- Decks
- 13 decks · latest Oct 27, 2025
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (October 2025) | Merger or acquisition | 28 slides | Oct 27, 2025 |
| Investor Day (September 2025) | Investor day | 24 slides | Sep 10, 2025 |
| Investor Day (June 2025) | Investor day | 38 slides | Jun 9, 2025 |
| Investor Day (March 2025) | Investor day | 32 slides | Mar 17, 2025 |
| Investor Day (November 2024) | Investor day | 38 slides | Nov 12, 2024 |
| Technical Presentation (August 2024) | Technical | 25 slides | Aug 9, 2024 |
| Technical Presentation (June 2024) | Technical | 47 slides | Jun 12, 2024 |
| Investor Day (March 2024) | Investor day | 35 slides | Mar 4, 2024 |
| Investor Day (April 2023) | Investor day | 45 slides | Apr 27, 2023 |
| Technical Presentation (December 2022) | Technical | 65 slides | Dec 14, 2022 |
All 13 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (December 2021) | Technical | 66 slides | Dec 9, 2021 |
| Investor Day (August 2021) | Investor day | 60 slides | Aug 2, 2021 |
| Investor Day (May 2021) | Investor day | 47 slides | May 19, 2021 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Carsten Boess Other companies: Atrium Therapeutics, Inc. (Director · Since at least Nov 10, 2025); Rocket Pharmaceuticals, Inc. (Director · Since at least Jan 11, 2016); Orchestra BioMed Holdings, Inc. (Director · Aug 3, 2020 – Aug 3, 2020 · Past); Synageva BioPharma Corp (SVP, Chief Financial Officer · Nov 2, 2011 – Jun 22, 2015 · Past); Insulet Corporation (Vice President, International · May 14, 2007 – Apr 25, 2011 · Past) | Director · Since at least Jun 11, 2020 |
| John Moriarty Other companies: Kardigan, Inc. (Chief Legal Officer and Corporate Secretary · Since at least Jun 17, 2026); Olema Pharmaceuticals, Inc. (EVP, Ch. Legal Officer & Sec. · Sep 19, 2020 – Feb 1, 2023 · Past); Portola Pharmaceuticals Inc (EVP, General Counsel · Mar 12, 2018 – Jul 2, 2020 · Past); Alexion Pharmaceuticals Inc (EVP & General Counsel · Dec 10, 2012 – Feb 6, 2018 · Past) | Chief Legal Officer · Since at least Aug 1, 2024 |
| Troy Wilson Other companies: Atrium Therapeutics, Inc. (Director · Since at least Nov 10, 2025); Kura Oncology, Inc. (Chairman · Since at least Mar 6, 2015); Puma Biotechnology Inc (Director · Since at least Oct 18, 2013); Zosano Pharma Corp (Director · Jan 26, 2015 – Jan 2, 2019 · Past) | Director · Since at least Jun 11, 2020 |
| Edward M. Kaye Other companies: Stoke Therapeutics, Inc. (Director · Since at least Jun 18, 2019); Cytokinetics, Incorporated (Director · Since at least May 18, 2016); Sarepta Therapeutics, Inc. (Chair of Scientific Advisory Board · Apr 24, 2012 – Nov 4, 2026 · Past) | Director · Since at least Jun 11, 2020 |
| Michael MacLean Other companies: Research Alliance Corporation III (Director · Since at least May 19, 2026); CAMP4 Therapeutics Corporation (Director · Since at least Mar 24, 2026); Verve Therapeutics Inc (Director · Since at least Jun 5, 2025) | Chief Financial Officer · Since at least Aug 6, 2025 |
| Steven George Hughes Other companies: Atrium Therapeutics, Inc. (Chief Medical Officer · Since at least Feb 26, 2026); Arcturus Therapeutics Holdings Inc. (Chief Development Officer · Feb 18, 2020 – Dec 18, 2020 · Past); VivoSim Labs, Inc. (Chief Medical Officer · Aug 1, 2018 – Aug 16, 2019 · Past) | Chief Medical Officer · Since at least Jan 6, 2025 |
| Jae B Kim Other companies: Septerna, Inc. (Chief Medical Officer · Since at least Oct 24, 2024); Design Therapeutics, Inc. (Chief Medical Officer · Mar 13, 2024 – Mar 13, 2024 · Past) | Chief Medical Officer · Jul 27, 2020 – Feb 2, 2021 · Past |
| Noreen Henig Other companies: Lazard Growth Acquisition Corp I (Director · Feb 9, 2021 – Feb 9, 2021 · Past); Kezar Life Sciences, Inc. (Chief Medical Officer · May 1, 2020 – Jul 24, 2023 · Past) | Director · Since at least Jun 11, 2020 |
| Simona Skerjanec Other companies: Atrium Therapeutics, Inc. (Director · Since at least Nov 10, 2025); Immunic, Inc. (Director · Since at least Jul 22, 2024) | Director · Since at least May 14, 2024 |
| Arthur Levin Other companies: Stoke Therapeutics, Inc. (Director · Since at least Jun 18, 2019) | Director · Since at least Jun 11, 2020 |
All 15 people
| Person | Seat |
|---|---|
| Joseph T. Baroldi Other companies: Ionis Pharmaceuticals, Inc. (Executive Vice President, Chief Business Officer · Since at least Jan 31, 2022) | Chief Operating Officer · Jun 11, 2020 – Feb 2, 2021 · Past |
| W. Michael Flanagan Other companies: Atrium Therapeutics, Inc. (Director · Since at least Nov 10, 2025) | Chief Scientific Officer · Since at least Jan 21, 2021 |
| Eric Mosbrooker | Chief Commercial Officer · Since at least Aug 25, 2021 |
| Michael B Martin | Director · Jun 11, 2020 – Jun 11, 2020 · Past |
| Teresa McCarthy | Chief Human Resources Officer · Since at least May 11, 2021 |
Log in to ask 6ix AI your own questions about Avidity Biosciences, Inc.